$96.81
0.54% yesterday
Nasdaq, Jul 01, 10:11 pm CET
ISIN
US5128073062
Symbol
LRCX

Lam Research Target price 2025 - Analyst rating & recommendation

Lam Research Classifications & Recommendation:

Buy
78%
Hold
22%

Lam Research Price Target

Target Price $95.37
Price $97.34
Deviation 2.02%
Number of Estimates 30
30 Analysts have issued a price target Lam Research 2026 . The average Lam Research target price is $95.37. This is 2.02% lower than the current stock price. The highest price target is $131.25 34.84% , the lowest is $70.70 27.37% .
A rating was issued by 37 analysts: 29 Analysts recommend Lam Research to buy, 8 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Lam Research stock has an average upside potential 2026 of 2.02% . Most analysts recommend the Lam Research stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029


Jun '24 2025
Estimates
Revenue Billion $ 14.91 18.62
14.48% 24.90%
EBITDA Margin 31.43% 33.89%
2.83% 7.82%
Net Margin 25.68% 28.20%
0.78% 9.81%

33 Analysts have issued a sales forecast Lam Research 2025 . The average Lam Research sales estimate is $18.6b . This is 8.64% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $19.2b 12.29% , the lowest is $17.7b 3.28% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $14.9b 14.48%
2025 $18.6b 24.90%
2026 $19.1b 2.41%
2027 $21.2b 11.27%
2028 $22.6b 6.53%
2029 $24.8b 9.93%

21 Analysts have issued an Lam Research EBITDA forecast 2025. The average Lam Research EBITDA estimate is $6.3b . This is 11.34% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.6b 16.67% , the lowest is $5.7b 1.06% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $4.7b 16.89%
2025 $6.3b 34.68%
2026 $6.3b 0.87%
2027 $7.2b 15.62%
2028 $7.9b 9.17%
2029 $8.7b 10.72%

EBITDA Margin

2024 31.43% 2.83%
2025 33.89% 7.82%
2026 32.81% 3.19%
2027 34.09% 3.90%
2028 34.93% 2.46%
2029 35.18% 0.72%

33 Lam Research Analysts have issued a net profit forecast 2025. The average Lam Research net profit estimate is $5.2b . This is 12.68% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $5.5b 17.41% , the lowest is $4.9b 6.04% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $3.8b 15.14%
2025 $5.2b 37.13%
2026 $5.3b 0.14%
2027 $6.1b 16.91%
2028 $6.9b 11.79%
2029 $7.8b 14.10%

Net Margin

2024 25.68% 0.78%
2025 28.20% 9.81%
2026 27.57% 2.23%
2027 28.97% 5.08%
2028 30.40% 4.94%
2029 31.55% 3.78%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Jun '24 2025
Estimates
Earnings Per Share $ 2.90 4.09
12.65% 41.03%
P/E 23.79
EV/Sales 6.64

33 Analysts have issued a Lam Research forecast for earnings per share. The average Lam Research EPS is $4.09 . This is 13.30% higher than earnings per share in the financial year 2024. The highest EPS forecast is $4.26 18.01% , the lowest is $3.85 6.65% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $2.90 12.65%
2025 $4.09 41.03%
2026 $4.10 0.24%
2027 $4.79 16.83%
2028 $5.36 11.90%
2029 $6.11 13.99%

P/E ratio

Current 26.96 30.62%
2025 23.79 11.77%
2026 23.76 0.13%
2027 20.32 14.48%
2028 18.18 10.53%
2029 15.93 12.38%

Based on analysts' sales estimates for 2025, the Lam Research stock is valued at an EV/Sales of 6.64 and an P/S ratio of 6.69 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.21 25.90%
2025 6.64 7.96%
2026 6.48 2.35%
2027 5.82 10.13%
2028 5.47 6.13%
2029 4.97 9.04%

P/S ratio

Current 7.27 25.67%
2025 6.69 7.96%
2026 6.53 2.35%
2027 5.87 10.13%
2028 5.51 6.13%
2029 5.01 9.04%

Current Lam Research Upgrades & Downgrades

Analyst Rating Action Date
Morgan Stanley
Equal-Weight
Equal-Weight
Unchanged Jul 01 2025
Cantor Fitzgerald
Overweight
Overweight
Unchanged Jun 24 2025
B. Riley Securities
Buy
Buy
Unchanged Jun 18 2025
Oppenheimer
Outperform
Outperform
Unchanged Jun 17 2025
Morgan Stanley
Equal-Weight
Equal-Weight
Unchanged Apr 24 2025
Cantor Fitzgerald
Overweight
Overweight
Unchanged Apr 24 2025
Evercore ISI Group
Outperform
Outperform
Unchanged Apr 24 2025
Analyst Rating Date
Unchanged
Morgan Stanley:
Equal-Weight
Equal-Weight
Jul 01 2025
Unchanged
Cantor Fitzgerald:
Overweight
Overweight
Jun 24 2025
Unchanged
B. Riley Securities:
Buy
Buy
Jun 18 2025
Unchanged
Oppenheimer:
Outperform
Outperform
Jun 17 2025
Unchanged
Morgan Stanley:
Equal-Weight
Equal-Weight
Apr 24 2025
Unchanged
Cantor Fitzgerald:
Overweight
Overweight
Apr 24 2025
Unchanged
Evercore ISI Group:
Outperform
Outperform
Apr 24 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today